This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

ZymoGenetics, Mitcham: Volume Movers

Stocks in this article: ZGEN MIND RTIX FLOW DJSP BMY

BOSTON ( TheStreet) -- ZymoGenetics (ZGEN) was one of several stocks trading below $10 poised to move on above-average volume Wednesday after the biotech company said it will be acquired in a $885 million deal.

ZymoGenetics rallied sharply after Bristol-Myers Squibb (BMY - Get Report) agreed to pay $9.75 a share for the biotech company, an 84% premium. Bristol-Myers said the deal gives it ownership of a "promising investigational biologic that strengthens our very diversified Hepatitis C portfolio."

Shares of ZymoGenetics surged by $4.43, or 83.6%, to $9.73 in the premarket session. The average daily share volume for ZymoGenetics is 390,000.

Elsewhere, Mitcham Industries (MIND - Get Report) climbed by 43 cents, or 6.7%, to $6.85 in Tuesday's after-market session after the seismic equipment company posted a second-quarter adjusted of 4 cents a share, surprising analysts who expected a loss of 6 cents a share. Revenue of $15.2 million was also better than analyst estimates. The average daily share volume for Mitcham is 34,000.

RTI Biologics (RTIX - Get Report) was poised to trade on increased volume after the human and animal tissue company cut its full-year earnings guidance to a range of 10 cents to 12 cents a share, compared to its prior range of 15 cents to 17 cents a share. The lower 2010 outlook comes as RTI Biologics announced a 10-year distribution agreement with Zimmer Dental for biologic implants for the dental market worldwide.

In addition, RTI Biologics reduced its full-year revenue guidance range to $165 million to $168 million from the previous range of $174.5 million to $177.5 million. The average daily share volume for RTI Biologics is 277,000. The stock closed Tuesday at $2.25.

Flow International (FLOW) rose by 7 cents, or 2.9%, to $2.45 in Tuesday's late trading session after the waterjet cutting company said it broke even on a per-share basis in its fiscal first quarter, compared to expectations for a loss of 3 cents a share. Revenue climbed 23% to $46.6 million, above the consensus for revenue of $44.4 million. The average daily share volume for Flow is 134,000.

DJSP Enterprises (DJSP) could see increased trading volume after the mortgage processing company said it had second-quarter earnings of 28 cents a share on revenue of $56.1 million, below estimates for earnings of 29 cents a share and revenue of $64.4 million. The average daily share volume for DJSP is 194,000. The stock closed Tuesday at $3.32.

-- Written by Robert Holmes in Boston.



>To contact the writer of this article, click here: Robert Holmes.

>To follow Robert Holmes on Twitter, go to http://twitter.com/RobTheStreet.

>To submit a news tip, send an email to: tips@thestreet.com.

Disclosure: TheStreet's editorial policy prohibits staff editors, reporters and analysts from holding positions in any individual stocks.

Check Out Our Best Services for Investors

Action Alerts PLUS

Jim Cramer and Stephanie Link reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

Jim Cramer's protégé, David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
Try it NOW
Try it NOW
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

Jim Cramer's protégé, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 17,672.60 -141.38 -0.79%
S&P 500 2,051.82 -11.33 -0.55%
NASDAQ 4,757.8790 +7.4820 0.16%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs